Ledgers bleed, but code remembers the truth. This one has no code.
A phantom valuation of $71 billion floats through the market. No SAFT. No on-chain transaction. No SEC filing. Just a story about a Chinese AI lab called DeepSeek, its founder Liang Wenfeng, and a shadowy secondary market built on SPVs with rising fees and five-year lockups.
I’ve seen this pattern before. In 2017, during the Ethereum Classic hard fork, I spent three weeks manually auditing the Geth client. The market was pricing in upgrades that the code couldn’t support. The same disconnect haunts this narrative: a valuation that treats propaganda as liquidity, but offers no verifiable proof of a single dollar changing hands.
Context: DeepSeek’s Real Footprint
DeepSeek is not a mirage. The lab has shipped real models—V3, R1, numerous open-weight releases under permissive licenses. Their API pricing is famously low: 0.5 yuan per million tokens for input. In my 2020 Uniswap V2 liquidity mining experiment, I learned that low fees attract massive volume. But they also compress margins. DeepSeek’s public strategy has been to prioritize adoption over revenue. Founder Liang has repeatedly stated the lab is funded by High-Flyer, his quantitative hedge fund, and that he does not seek external capital.
Until, supposedly, June 2026. The narrative claims a $7.4 billion raise at a $52 billion post-money valuation, with Liang personally injecting $3 billion. Then a second round that targets a $71 billion pre-money, paused on July 25 after leaked remarks about dependence on Nvidia chips. Then a secondary market that magically prices at $71 billion. All of this allegedly leads to a 2027 STAR Market IPO.
But the facts don’t match. The naming scheme “V4-Pro” does not exist in DeepSeek’s release history. Moonshot (the $50 billion Hong Kong IPO candidate) was valued at $3.3 billion in August 2024. A 15x jump in two years is not impossible, but it requires a revenue trajectory that no public data supports.
Core: The Order Flow of an Opaque SPV
Let me quantify what this story actually reveals. The implied price-to-sales ratio at $71 billion against a claimed $500 million ARR is 142x. That’s not absurd on its own—Anthropic trades near 180x on forward revenue growth. But here is the fracture: Anthropic’s multiple is backed by 10x year-over-year growth. For DeepSeek, the report provides zero growth rate. Zero.
If I apply a standard discounted cash flow model with a 15% discount rate and a 5-year horizon, a 142x P/S with no growth implies the market expects revenue to collapse. The multiple only works if you assume explosive growth. But the narrative doesn’t show that. Instead, it relies on a single line: “DeepSeek is treated as national infrastructure.” That is not a financial thesis. That is regulatory theology.
Now dissect the SPV mechanics. The article states that SPVs are “characterized by increasing fees and 5-year lock-ups.” In a typical pre-IPO SPV, total fees (placement + management) range from 5% to 15%. If an investor buys at a $71 billion nominal valuation, the effective cost becomes $78–$85 billion. Five years of lock-up at a 10% annual hurdle means the exit valuation must reach $110–$140 billion just to break even in real terms. The market is asking for a doubling of the already unverifiable $71 billion. Liquidity is just trust, quantified in gas. Here, the gas is 142x P/S and a lock-up that outlasts most crypto bull cycles.
Liquidity is just trust, quantified in gas.
Contrarian: The Valuation Is a Sovereign Utility Option, Not a Market Price
The report’s deepest insight is the contrast between US and Chinese AI valuation logic. US labs like Anthropic are priced on growth and revenue multiples. Chinese labs, the narrative claims, are priced as “national infrastructure.” This is not a premium; it is a different asset class. It is a call option on policy continuity. The moment the state stops backing the narrative, the SPV investors are left with a 142x P/S company that has no growth story and no secondary market.
Security is a myth until the bridge breaks.
The founder’s leaked comment about Nvidia dependence reveals the weakest point. If DeepSeek must shift to domestic chips (Huawei Ascend, Cambricon), inference efficiency could drop 30–70%, crushing the claimed 70–80% gross margins. The $71 billion valuation is effectively pricing the optionality of a successful chip transition. If that fails, the bridge collapses. And the SPV investors hold the bag.
Takeaway: Act on What Can Be Verified, Not on What Is Narrated
I run a copy trading community. My members know that on-chain data beats headlines every time. For DeepSeek, the on-chain data is missing. No token, no verified wallet, no revenue signature on any public ledger. The narrative itself admits this: the $500 million ARR is an estimate, not a disclosed figure. The $71 billion valuation is a secondary market number, not a priced round.
Every exploit is a lesson paid for in ETH.
The lesson here is that narrative-based valuations in unverified SPVs are not investments—they are contributions to a story. If you must engage, demand proof of cash flow, not just proof of concept. Watch for any real on-chain activity from DeepSeek. Watch for actual revenue disclosures. Until then, the ghost of $71 billion remains a ghost.